Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Merrimack Pharmaceuticals Inc. logo

Merrimack Pharmaceuticals Inc.

Sector: Healthcare   

Industry: Biotechnology

0.03
 
USD
  
0.00
  
(0.00%)
Optionable: Yes  Market Cap: 0 M  90-day average vol: 177,698

Previous close: 0.03  Open: 15.15  Bid:   Ask:
52 week range    
11.53   
   15.89
Last updated: Monday 24th June 2024

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)
Financials

MACK Income Statement

Annual
Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23
Amortization of intangibles0.0-400000.00.0
Basic EPS from continuing operations-0.23-0.18-0.11-0.08
Basic EPS total-0.23-0.18-0.11-0.08
Basic weighted shares outstanding10 M11 M13 M13 M13 M13 M13 M13 M14 M14 M
Cost of sales-169 M-46000.00.0
Depreciation-4 M-5 M-6 M-5 M-4 M0.0
DepreciationAndAmortization-4 M-5 M-6 M-5 M-4 M-2 M
Diluted EPS total-8.0-13.3-12.141.331.520.29-0.23-0.18-0.11-0.08
Diluted normalized net income/share-0.11-0.08
Diluted weighted shares outstanding10 M11 M13 M11 M27 M13 M13 M13 M14 M14 M
DilutedDiscontinuousOperations0.29
Dividends paid per share10.55
Earnings from equity interest-849000.0-3 M1 M
EarningsFromEquityInterestNetOfTax-849000.0-3 M1 M
GainOnSaleOfPPE2 M5 M2 M144000.0445000.0139000.0
GainOnSaleOfSecurity11 M
GainsLossOnDisposalOfDiscontinuedOperations3 M547 M20 M4 M
GeneralAndAdministrativeExpense-6 M-7 M32 M28 M16 M16 M5 M3 M2 M2 M
Gross operating profit103 M89 M137 M
ImpairmentOfCapitalAssets0.0
Income before tax-84 M-163 M-170 M-118 M-68 M-23 M-3 M-2 M-2 M-1 M
Income restructuring and M&A6 M-10 M-1 M-5 M
Income taxes0.0-13 M-42 M-8 M-1 M14000.03000.03000.012000.0
Interest income114000.099000.0276000.0895000.01 M777000.050000.020000.0188000.0868000.0
InterestExpenseNonOperating18 M19 M22 M35 M956000.02 M
MinorityInterests268000.0-170000.02 M1 M
MiscOtherSpecialCharges813000.0917000.0-8000.0-1 M-3 M370000.0-191000.0
Net income from total operations-83 M-148 M-152 M472 M-41 M-17 M-3 M-2 M-2 M-1 M
NetIncomeCommonStockholders-83 M-148 M-152 M472 M-41 M-17 M-3 M-2 M-2 M-1 M
NetIncomeContinuousOperations-83 M-148 M-152 M472 M-41 M-17 M-3 M-2 M-2 M-1 M
NetIncomeDiscontinuousOperations2 M303000.03 M547 M20 M4 M
NetNonOperatingInterestIncomeExpense-18 M-19 M-22 M-34 M343000.0-751000.050000.020000.0188000.0868000.0
Normalized income-2 M-1 M
Operating income-66 M-130 M-142 M-96 M-66 M-27 M-3 M-2 M-2 M-2 M
Operating income before depreciation (EBITDA)-62 M-139 M-142 M-79 M-64 M-19 M-3 M-2 M-2 M-1 M
OperatingExpense169 M219 M142 M-96 M-66 M27 M3 M2 M2 M2 M
Other income net-813000.0-917000.08000.0-11 M3 M-5 M-2 M-144000.0-445000.0-139000.0
OtherGandA-6 M-7 M32 M28 M16 M16 M5 M3 M2 M2 M
OtherImpairmentOfCapitalAssets-3 M
PromotionAndAdvertising-1000000.00.0
ProvisionForGainLossOnDisposal2 M0.0
RentAndLandingFees-6 M0.032 M28 M16 M
Research & development expense138 M161 M110 M67 M50 M11 M
ResearchExpense138 M161 M110 M67 M50 M11 M
RestructringAndMnAIncome6 M-10 M-1 M-5 M
Revenue per share-320000.0-400000.0-600000.0
SalariesAndWages-13 M-15 M-12 M0.00.0
Selling Gen & administrative expense31 M58 M32 M28 M16 M16 M5 M3 M2 M2 M
SellingAndMarketingExpense31 M58 M81 M
SellingExpense31 M58 M81 M
Special income/charges-6 M10 M1 M5 M
Total Income available for interest expense (EBIT)-65 M-144 M-147 M-84 M-68 M-21 M-3 M-2 M-2 M-1 M
Total common shares outstanding11 M12 M13 M13 M13 M13 M13 M13 M14 M15 M
Total net income-83 M-148 M-152 M472 M-41 M-17 M-3 M-2 M-2 M-1 M
Total ordinary shares15 M15 M15 M15 M15 M15 M15 M15 M15 M15 M
Total revenues103 M89 M0.0
TotalExpenses169 M219 M0.0-96 M-66 M27 M3 M2 M2 M2 M
TotalRevenue103 M4 M53 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University